Ligands and oxidants in ferrihemochrome formation and oxidative hemolysis.
We have investigated the effect of size of a single neutral ring substituent on the induction of hemolytic anemia and the formation of a ferrihemochrome by substituted phenylhydrazines. The severity of induced anemia decreased with increase in size of a halogen atom or an alkyl group ortho to the hydrazino group, little anemia resulting from 2-iodophenylhydrazine and no anemia from 2-tert-butylphenylhydrazine. The size of a halogen atom or an alkyl group at the meta or para position had relatively little effect on the severity of induced anemia. The ability of an arylhydrazine to induce hemolytic anemia paralleled its ability to produce a ferrihemochrome with an exogenous ligand, probably the corresponding aryldiazene. In general, rapid and complete formation of ferrihemochrome occurred with arylhydrazines that induced severe anemia. The degree of hemolysis induced by an arylhydrazine was not related to its rate of autooxidation, i.e., the rate at which oxidants are formed by the reduction of oxygen. We propose a mechanism of arylhydrazine-induced oxidative denaturation based on the simultaneous formation of hydroxyl radical and aryldiazene ferrihemochrome in a reaction of oxyhemoglobin with arylhydrazine. We suggest that after oxidation of the porphyrin ring is initiated by a hydroxyl radical, oxidative cleavage of the ring is facilitated by the presence of a large ligand in the heme crevice. Thus, aryldiazene ferrihemochrome may contribute to instability in a hemoglobin molecule, whereas globin ferrihemochrome results from instability.
D000743:Anemia, Hemolytic / Q000097:blood* / Q000139:chemically induced; D000818:Animals; D001772:Blood Cell Count; D006400:Hematocrit; D007700:Kinetics; D008024:Ligands; D008706:Methemoglobin / Q000378:metabolism*; D010084:Oxidation-Reduction; D010100:Oxygen / Q000097:blood; D010659:Phenylhydrazines; D011485:Protein Binding; D011817:Rabbits; D012156:Reticulocytes / Q000502:physiology; D013053:Spectrophotometry; D013329:Structure-Activity Relationship
D008024:Ligands; D010659:Phenylhydrazines; D008706:Methemoglobin; D010100:Oxygen
Biochem Biophys Res Commun. 1975 Feb 3;62(3):561-7
1120068
Blood. 1961 Apr;17:418-33
13711607
J Mol Biol. 1964 Jan;8:96-104
14149967
Br J Haematol. 1976 Jan;32(1):99-104
1259930
J Chem Soc Perkin 1. 1972;20:2540-8
4674785
Pharmacol Rev. 1969 Mar;21(1):73-103
4887725
Proc Soc Exp Biol Med. 1974 Dec;147(3):656-8
4445150
Prog Hematol. 1971;7(0):69-109
4950839
Proc R Soc Lond B Biol Sci. 1969 May 20;173(1031):113-40
4389425
Biochemistry. 1976 Feb 10;15(3):681-7
175827
Semin Hematol. 1969 Apr;6(2):116-32
4890092
J Mol Biol. 1976 Jul 5;104(3):707-22
950675
Medicine (Baltimore). 1955 May;34(2):131-92
14383004
Proc Natl Acad Sci U S A. 1970 Oct;67(2):485-92
5289003
Biochem Soc Trans. 1976;4(2):209-14
1001644
J Biol Chem. 1971 May 25;246(10):3356-66
4324898
Biochem J. 1976 Jun 1;155(3):493-502
182128
J Mol Biol. 1976 Jul 5;104(3):687-706
950674
Br J Haematol. 1975 Jul;30(3):259-64
172110
Blood. 1968 Jun;31(6):766-77
4871702
Biochim Biophys Acta. 1976 Jan 14;421(1):87-96
1247590
Blood. 1965 Oct;26(4):433-48
5825007
Nature. 1954 Feb 27;173(4400):389-91
13144768
Blood. 1968 Jun;31(6):778-90
5654969
Biochim Biophys Acta. 1975 Jun 26;393(2):404-18
167836
Biochemistry. 1964 Jul;3:895-900
14214074
Nature. 1975 Aug 21;256(5519):665-7
1153002
Br J Haematol. 1974 Apr;26(4):513-7
4367628
Biochem Biophys Res Commun. 1974 Apr 23;57(4):1104-10
4830750
Blood. 1968 Mar;31(3):388-95
5640633
Biochem Pharmacol. 1968 Mar;17(3):423-7
4173613
Acta Haematol. 1962;27:321-33
13868714
Ann N Y Acad Sci. 1975 Apr 15;244:533-52
1094885
J Clin Invest. 1960 Dec;39:1818-36
13789379
J Am Chem Soc. 1975 Sep 17;97(19):5363-9
1159229
J Biol Chem. 1975 Mar 25;250(6):2401-3
163828
J Biol Chem. 1976 May 25;251(10):3045-51
5452
Arch Biochem Biophys. 1957 Sep;71(1):235-49
13459445
FEBS Lett. 1969 Nov 29;5(4):295-298
11947301
Nature. 1968 Aug 31;219(5157):902-9
5691676